PMID- 26584702 OWN - NLM STAT- MEDLINE DCOM- 20160909 LR - 20151120 IS - 1525-1470 (Electronic) IS - 0736-8046 (Linking) VI - 32 IP - 6 DP - 2015 Nov-Dec TI - Febrile Ulceronecrotic Mucha-Habermann Disease: Two Cases with Excellent Response to Methotrexate. PG - e307-8 LID - 10.1111/pde.12687 [doi] AB - Febrile ulceronecrotic Mucha-Habermann disease (FUMHD), a severe form of pityriasis lichenoides et varioliformis acuta (PLEVA), featuring large, ulcerative, necrotic skin plaques, high fever, and other systemic symptoms, is a rare disorder of unknown etiology. No randomized controlled trials have established treatment guidelines and multiple modalities are often employed, making it difficult to assess the efficacy of any single agent. We report two cases of this condition in which treatment with methotrexate plus antibiotic treatment for superinfection led to rapid improvement. CI - (c) 2015 Wiley Periodicals, Inc. FAU - Griffith-Bauer, Kelly AU - Griffith-Bauer K AD - Department of Dermatology, Center for Health and Healing, Oregon Health and Science University, Portland, Oregon. FAU - Leitenberger, Sabra L AU - Leitenberger SL AD - Department of Dermatology, Center for Health and Healing, Oregon Health and Science University, Portland, Oregon. FAU - Krol, Alfons AU - Krol A AD - Department of Dermatology, Center for Health and Healing, Oregon Health and Science University, Portland, Oregon. LA - eng PT - Journal Article DEP - 20151008 PL - United States TA - Pediatr Dermatol JT - Pediatric dermatology JID - 8406799 RN - OBN7UDS42Y (Cephalexin) RN - YL5FZ2Y5U1 (Methotrexate) RN - Febrile Ulceronecrotic Mucha-Habermann disease SB - IM MH - Biopsy, Needle MH - Cephalexin/administration & dosage MH - Child MH - Dose-Response Relationship, Drug MH - Drug Administration Schedule MH - Drug Therapy, Combination MH - Exanthema/diagnosis/etiology MH - Fever/diagnosis/etiology MH - Follow-Up Studies MH - Herpes Simplex/*diagnosis/*drug therapy MH - Hospitalization MH - Humans MH - Immunohistochemistry MH - Male MH - Methotrexate/*administration & dosage MH - Pityriasis Lichenoides/*diagnosis/*drug therapy MH - Rare Diseases MH - Risk Assessment MH - Sampling Studies MH - Severity of Illness Index MH - Superinfection/drug therapy/*prevention & control MH - Treatment Outcome EDAT- 2015/11/21 06:00 MHDA- 2016/09/10 06:00 CRDT- 2015/11/21 06:00 PHST- 2015/11/21 06:00 [entrez] PHST- 2015/11/21 06:00 [pubmed] PHST- 2016/09/10 06:00 [medline] AID - 10.1111/pde.12687 [doi] PST - ppublish SO - Pediatr Dermatol. 2015 Nov-Dec;32(6):e307-8. doi: 10.1111/pde.12687. Epub 2015 Oct 8.